Pharmaceutical Promotion: Don't Throw The Baby Out With The Bathwater
- 1 January 2003
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 22 (Suppl1) , W3-96
- https://doi.org/10.1377/hlthaff.w3.96
Abstract
Spending on prescription drugs and promotion by the pharmaceutical industry grew substantially during the past ten years. Does the greater exposure offered by promotion fill a needed educational gap, or does it merely promote inappropriate use? This paper uses two recent studies to explore this question, presenting a framework in which the impact of promotion depends upon the level of evidence and consensus on drug use.Keywords
This publication has 8 references indexed in Scilit:
- The Consumer and the Learned Intermediary in Health CareNew England Journal of Medicine, 2002
- Promotion of Prescription Drugs to ConsumersNew England Journal of Medicine, 2002
- Geographic Variation In The Use Of Medications: Is Uniformity Good News Or Bad?Health Affairs, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Direct-to-consumer advertising of prescription drugsWestern Journal of Medicine, 2000
- Direct-to-consumer prescription drug advertising and the publicJournal of General Internal Medicine, 1999
- Variation profiles of common surgical proceduresSurgery, 1998
- Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial InfarctionNew England Journal of Medicine, 1998